Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/4/19 → 12/4/24 |
Funding
- AbbVie Inc. (Prot #M14-239)
Prot #M14-239: Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer
- Mohindra, Nisha A (PD/PI)
Project: Research project